cRGD-ZW800-1
NL74742.078.20
Phase 2 small_molecule active
Quick answer
cRGD-ZW800-1 for Squamous cell carcinoma of the larynx and hypopharynx is a Phase 2 program (small_molecule) at Disc Medicine with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Disc Medicine
- Indication
- Squamous cell carcinoma of the larynx and hypopharynx
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active